These were the seven biggest deals closed or announced in 2018:
1. Takeda’s planned takeover of Shire: $77 billion
2. Cigna’s acquisition of Express Scripts: $68.5 billion
3. GlaxoSmithKline’s agreement to purchase of Novartis’s stake in a consumer health joint venture: $13 billion
4. Sanofi’s agreement to buy Bioverati: $10.9 billion
5. KKR’s acquisition of Nashville, Tenn.-based Envision Healthcare: $9.5 billion
6. Celgene’s acquisition of Juno: $8.9 billion
7. Novartis’ agreement to acquire AveXis: $8.1 billion
Click here to read more about the companies and how the transactions could shape healthcare.
More articles on transactions/valuation:
PE deals in healthcare increase 200%+ in a decade — What’s in store for 2019?
5 predictions for ophthalmology PE in 2019 — AmSurg, USPI & more
Conemaugh Health System breaks ground on outpatient center — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
